Skip to content
Discover J&J
Medicines & therapies
Medical devices & technology
Discover J&J
Medicines & therapies
Medical devices & technology
Center for
U.S. Healthcare
Policy Research
Research
areas
Research areas
Value
Access
Innovation
All content
Transparency Report
& Issue Briefs
Perspectives
& insights
About us
Menu
Center for
U.S. Healthcare
Policy Research
Research
areas
Research areas
Value
Access
Innovation
All content
Transparency Report
& Issue Briefs
Perspectives
& insights
About us
Show Search
Search Query
Clear
Submit Search
Dictate search request
Listening...
Search Results
No Results
See all results
Sorry, I don't understand. Please try again
Search results
Search Query
Submit Search
Listening...
There are 110 results that match your search.
Innovation
April 22, 2024
Life years gained from the FDA accelerated approval program in oncology
A portfolio model
Read more
Access
November 14, 2024
Economic evidence on cost sharing and alternative insurance designs
Addressing moral and behavioral hazards in high-income healthcare systems: a systematic review
Read more
Value
March 8, 2025
A review of heterogeneity in comparative economic analysis
With specific considerations for the decentralized U.S. setting and patient-centered care
Read more
Access
September 7, 2023
Patient perceptions of copay card utilization and policies
Read more
Innovation
October 3, 2024
Public sector replacement of privately funded pharmaceutical R&D
Cost and efficiency considerations
Read more
Transparency Report & Issue Briefs
September 1, 2024
$42.8 billion: Breaking it down
2023 Rebates, discounts and fees
Read more
Transparency Report & Issue Briefs
September 1, 2024
2023 rebates, discounts and fees
Read more
Transparency Report & Issue Briefs
November 1, 2022
How insurers divert copay support meant for patients
Janssen health equity Policy Brief
Read more
Transparency Report & Issue Briefs
September 1, 2024
2023 Johnson & Johnson Innovative Medicine U.S. pricing transparency report
Creating the next era of healthcare advancements for patients
Read more
Innovation
August 6, 2024
Comprehensive measurement of biopharmaceutical R&D investment
Read more
1 of 11
